Pol Arch Intern Med. 2017 Nov 30;127(11):785-789. doi: 10.20452/pamw.4123. Epub 2017 Oct 25.
Recently, many countries have enacted new cannabis policies, including decriminalization of cannabis possession as well as legalization of medical and recreational cannabis. In this context, patients and their physicians have had an increasing number of conversations about the risks and benefits of cannabis. While cannabis and cannabinoids continue to be evaluated as pharmacotherapy for medical conditions, the best evidence currently exists for the following medical conditions: chronic pain, neuropathic pain, and spasticity resulting from multiple sclerosis. We also reviewed the current state of evidence for cannabis and cannabinoids for several other medical conditions, while addressing the potential acute and chronic effects of cannabis use, which are issues that physicians must consider before making an official recommendation on the use of medical cannabis to a patient. As the number of patient requests for medical cannabis has been increasing, physicians must become knowledgeable on the science of medical cannabis and open to a discussion about why the patient feels that medical cannabis may be helpful.
最近，许多国家都制定了新的大麻政策，包括将大麻持有非刑罪化以及将医用和休闲用大麻合法化。在这种背景下，患者及其医生越来越多地就大麻的风险和益处进行对话。虽然大麻和大麻素仍在作为药物治疗方法用于评估医疗状况，但目前针对以下医疗状况的最佳证据是：慢性疼痛、神经病理性疼痛和多发性硬化症引起的痉挛。我们还审查了大麻和大麻素在其他几种医疗状况下的现有证据，同时解决了大麻使用的潜在急性和慢性影响，这是医生在向患者推荐使用医用大麻之前必须考虑的问题。随着患者对医用大麻的需求不断增加，医生必须了解医用大麻的科学知识，并愿意讨论患者认为医用大麻可能有帮助的原因。
